Feedback / Questions
suvratoxumab (MEDI4893) - AstraZeneca, Aridis
http://clinicaltrials.gov/ct2/show/NCT05331885
Mar 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next